SCHEMBL487257

SCHEMBL487257

OC(O)Nc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.55
CA12 O43570 1/20 0.50
CA9 Q16790 1/20 0.50
IDO1 P14902 2/20 0.48
ALDH1A1 P00352 6/20 0.46
HSD17B10 Q99714 6/20 0.46
TSHR P16473 6/20 0.46
CYP3A4 P08684 4/20 0.46
ALOX15 P16050 3/20 0.46
ALOX12 P18054 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
LMNA P02545 2/20 0.46
THRB P10828 1/20 0.46
RECQL P46063 1/20 0.46
ATM Q13315 1/20 0.46
CTSD P07339 1/20 0.45
PTGS2 P35354 2/20 0.43
MAPK1 P28482 2/20 0.43
PTGS1 P23219 1/20 0.43
SLC6A2 P23975 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21162820 0.82 TDP1 (0.55) TDP1CA12CA9IDO1ALDH1A1
SCHEMBL10438956 0.79 CA12 (0.48) TDP1CA12CA9ALDH1A1HSD17B10
SCHEMBL1973980 0.79 CA12 (0.48) TDP1CA12CA9ALDH1A1HSD17B10
SCHEMBL27269638 0.78 TDP1 (0.50) TDP1CA12CA9IDO1ALDH1A1
SCHEMBL42138 0.78 TDP1 (0.64) TDP1CA12CA9IDO1ALDH1A1
SCHEMBL8193205 0.76 TDP1 (0.48) TDP1CA12CA9IDO1ALDH1A1
Water SCHEMBL11613455 0.76 TDP1 (0.61) TDP1CA12CA9IDO1ALDH1A1
Hydrochloric Acid SCHEMBL7930921 0.76 TDP1 (0.61) TDP1CA12CA9IDO1ALDH1A1
SCHEMBL21586403 0.76 TDP1 (0.43) TDP1CA12CA9IDO1ALDH1A1
SCHEMBL21162821 0.75 TDP1 (0.60) TDP1CA12CA9IDO1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110972537-B Ablation-resistant phenolic resin composition and preparation method thereof 华东理工大学 2014-07-30 CN claimed
CN-110972536-B Preparation method of ablation-resistant phenolic resin for RTM (resin transfer molding) and phenolic resin composition 华东理工大学 2014-02-12 CN claimed
EP-0549263-A2 A process for the preparation of N-alkyl-3,4-dialkyloxyanilines and derivatives thereof CHEMAGIS LTD. (IL) 1993-06-30 EP claimed
US-9593197-B2 Trigger-responsive chain-shattering polymers THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2017-03-14 US disclosed
US-20150141453-A1 Trigger-Responsive Chain-Shattering Polymers THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2015-05-21 US disclosed
EP-2831142-A2 TRIGGER-RESPONSIVE CHAIN-SHATTERING POLYMERS The Board Of Trustees Of The University Of Illinois (US) 2015-02-04 EP disclosed
CN-110972536-B Preparation method of ablation-resistant phenolic resin for RTM (resin transfer molding) and phenolic resin composition 华东理工大学 2014-02-12 CN disclosed
US-20130338363-A1 SILANE COMPOUND, PRODUCTION METHOD THEREOF, AND RESIN COMPOSITION CONTAINING SILANE COMPOUND NIPPON SHOKUBAI CO., LTD. (JP) 2013-12-19 US disclosed
WO-2013173834-A2 TRIGGER-RESPONSIVE CHAIN-SHATTERING POLYMERS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2013-11-21 WO disclosed
US-8541532-B2 Silane compound, production method thereof, and resin composition containing silane compound NIPPON SHOKUBAI CO., LTD. (JP) 2013-09-24 US disclosed
EP-2180019-B1 Resin composition, method of its composition, and cured formulation NIPPON CATALYTIC CHEM IND (JP) 2012-02-01 EP disclosed
WO-2003099934-A1 FIRE RETARDANT RESIN COMPOSITION, METHOD OF ITS PRODUCTION, SHAPED ARTICLES COMPRISING THE SAME, AND SILICA NIPPON SHOKUBAI CO., LTD. (JP) 2003-12-04 WO disclosed
EP-1066039-A4 SUBSTITUTED QUINAZOLINES AND ANALOGS AND THE USE THEREOF COCENSYS INC (US) 2003-02-26 EP disclosed
EP-1073633-A2 SUBSTITUTED BETA-AMINO ACID INHIBITORS OF METHIONINE AMINOPEPTIDASE-2 ABBOTT LABORATORIES (US) 2001-02-07 EP disclosed
EP-1073639-A1 QUINOLINE DERIVATIVES Active Biotech AB (SE) 2001-02-07 EP disclosed
EP-1066039-A1 SUBSTITUTED QUINAZOLINES AND ANALOGS AND THE USE THEREOF Cocensys, Inc. (US) 2001-01-10 EP disclosed
WO-1999057098-A2 SUBSTITUTED BETA-AMINO ACID INHIBITORS OF METHIONINE AMINOPEPTIDASE-2 ABBOTT LABORATORIES (US) 1999-11-11 WO disclosed
WO-1999055678-A1 QUINOLINE DERIVATIVES ACTIVE BIOTECH AB (SE) 1999-11-04 WO disclosed
WO-1999044612-A1 SUBSTITUTED QUINAZOLINES AND ANALOGS AND THE USE THEREOF COCENSYS, INC. (US) 1999-09-10 WO disclosed
EP-0331357-A1 4-Amino-3-acylquinoline derivatives and their use as inhibitors of gastric secretion SMITHKLINE BECKMAN INTERCREDIT B.V. (NL) 1989-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150141453-A1 Trigger-Responsive Chain-Shattering Polymers SGTA, FUS, EWSR1 TDP1 1997/4885CA12 1121/4885CA9 2513/4885
US-20130338363-A1 SILANE COMPOUND, PRODUCTION METHOD THEREOF, AND RESIN COMPOSITION CONTAINING SILANE COMPOUND ZYX, NOX3, NOXO1 TDP1 4791/4885CA12 1733/4885CA9 2608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.